Target Name: ZNF385A
NCBI ID: G25946
Review Report on ZNF385A Target / Biomarker Content of Review Report on ZNF385A Target / Biomarker
ZNF385A
Other Name(s): HZF | Zinc finger protein 385A (isoform a) | Hematopoietic zinc finger protein | Zinc finger protein 385A, transcript variant 1 | Zinc finger protein 385 | ZNF385A variant 1 | Zinc finger protein 385A | Z385A_HUMAN | zinc finger protein 385A | ZNF385 | retinal zinc finger protein | Retinal zinc finger protein | RZF | ZFP385 | hematopoietic zinc finger protein | zinc finger protein 385

ZNF385A: A Potential Drug Target and Biomarker for treating Mental Health Disorders

Mental health disorders are a significant public health issue, affecting millions of people worldwide. The development of new treatments is crucial to address these disorders, and ZNF385A, also known as HZF, has the potential to be a valuable drug target and biomarker for treating mental health disorders. In this article, we will discuss the potential mechanisms of ZNF385A and its potential as a drug target for treating mental health disorders.

Potential Mechanisms of ZNF385A as a Drug Target

ZNF385A is a non-coding RNA molecule that is expressed in various tissues and cells in the body. It is a key regulator of neural development and function, and has been implicated in the development and progression of several mental health disorders.

One of the potential mechanisms by which ZNF385A may contribute to the development of mental health disorders is its role in the regulation of brain-derived neurotrophic factor (BDNF), a protein that promotes brain health and is often impaired in mental health disorders. BDNF is a key regulator of neuron survival and differentiation, and is implicated in the development of several mental health disorders, including depression, anxiety, and schizophrenia.

ZNF385A has been shown to play a role in the regulation of BDNF, by promoting its levels in the brain and inhibiting its degradation. This may contribute to the development of mental health disorders by impairing the normal regulation of BDNF.

Another potential mechanism by which ZNF385A may contribute to the development of mental health disorders is its role in the regulation of the microRNA (miRNA) system, a complex of small non-coding RNAs that play a critical role in gene expression. miRNA systems have been implicated in the regulation of many mental health disorders, including depression, anxiety, and schizophrenia.

ZNF385A has been shown to play a role in the regulation of miRNA systems by promoting the levels of miR-202, a miRNA that is known to be involved in the regulation of BDNF. This may contribute to the development of mental health disorders by impairing the normal regulation of miRNA systems.

Potential as a Biomarker for Mental Health Disorders

ZNF385A may also have the potential as a biomarker for the diagnosis and progression of mental health disorders. The development of biomarkers, or indicators of disease, can be useful for identifying and detecting the early stages of disease, which is crucial for the development of effective treatments.

ZNF385A has been shown to be expressed in various tissues and cells in the body, including brain, and has been implicated in the development and progression of several mental health disorders. This suggests that it may be a useful biomarker for the diagnosis and progression of mental health disorders.

In addition, ZNF385A has been shown to play a role in the regulation of neural development and function, which is critical for the development and progression of mental health disorders. This suggests that it may be a useful biomarker for the development and progression of mental health disorders.

Conclusion

ZNF385A is a non-coding RNA molecule that has the potential to be a drug target and biomarker for treating mental health disorders. Its role in the regulation of BDNF and miRNA systems, as well as its potential as a biomarker for the diagnosis and progression of mental health disorders, makes it an attractive target for further research. Further studies are needed to determine the full potential of ZNF385A as a drug target and biomarker for treating mental health disorders.

Protein Name: Zinc Finger Protein 385A

Functions: RNA-binding protein that affects the localization and the translation of a subset of mRNA. May play a role in adipogenesis through binding to the 3'-UTR of CEBPA mRNA and regulation of its translation. Targets ITPR1 mRNA to dendrites in Purkinje cells, and may regulate its activity-dependent translation. With ELAVL1, binds the 3'-UTR of p53/TP53 mRNAs to control their nuclear export induced by CDKN2A. Hence, may regulate p53/TP53 expression and mediate in part the CDKN2A anti-proliferative activity. May also bind CCNB1 mRNA. Alternatively, may also regulate p53/TP53 activity through direct protein-protein interaction. Interacts with p53/TP53 and promotes cell-cycle arrest over apoptosis enhancing preferentially the DNA binding and transactivation of p53/TP53 on cell-cycle arrest target genes over proapoptotic target genes. May also regulate the ubiquitination and stability of CDKN1A promoting DNA damage-induced cell cycle arrest. Also plays a role in megakaryocytes differentiation

The "ZNF385A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF385A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521